World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
56
Citations
9775
World Ranking
11791
National Ranking
3168

Research.com Recognitions

  • 1994 - Fellow of the Royal Society, United Kingdom

Overview

Raymond Baker is affiliated with MSD in the United States. Their research primarily lies within the field of chemistry, with a particular focus on organic chemistry. Their work spans several subfields including molecular biology, pharmacology, computational theory and mathematics, and toxicology.

The scientist's research centers on various topics, including:

  • Synthesis and biological activity
  • Synthesis and Biological Evaluation
  • Multicomponent Synthesis of Heterocycles
  • Synthesis and Characterization of Heterocyclic Compounds
  • Quinazolinone synthesis and applications
  • Click Chemistry and Applications
  • Phenothiazines and Benzothiazines Synthesis and Activities

Recent significant papers authored or co-authored by Raymond Baker include:

  • "Synthesis of Chalcones Derivatives and Their Biological Activities: A Review" (2022), published in ACS Omega
  • "Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment" (2020), published in Medicinal Chemistry Research
  • "New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study" (2021), published in Molecules
  • "Efficient and Recoverable Bio-Organic Catalyst Cysteine for Synthesis, Docking Study, and Antifungal Activity of New Bio-Active 3,4-Dihydropyrimidin-2(1H)-ones/thiones Under Microwave Irradiation" (2022), published in ACS Omega
  • "Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights" (2020), published in Bioorganic & Medicinal Chemistry

Collaborations are an essential part of Raymond Baker's research, with frequent co-authors including:

  • Nadia A. A. Elkanzi
  • Mohamed A. Abdelgawad
  • Hajer Hrichi
  • Mohammed M. Ghoneim
  • Della Grace Thomas Parambi

Publications have appeared extensively in venues such as:

  • Chemistry & Biodiversity
  • Letters in Drug Design & Discovery
  • ACS Omega
  • Arabian Journal of Chemistry
  • Molecules

Raymond Baker was recognized as a Fellow of the Royal Society, United Kingdom, in 1994, an acknowledgment within the scientific community.

Best Publications

  • 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.

    P D Leeson;R W Carling;K W Moore;A M Moseley

  • Novel 5-HT3 antagonists. Indole oxadiazoles.

    C. J. Swain;R. Baker;C. Kneen;J. Moseley

  • Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

    John Saunders;Mark Cassidy;Stephen B. Freedman;Elizabeth A. Harley

  • Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.

    Paul D. Leeson;Raymond Baker;Robert W. Carling;Neil R. Curtis

  • Total Synthesis and Determination of the Absolute Configuration of Epibatidine

    Stephen R. Fletcher;Raymond Baker;Mark S. Chambers;Richard H. Herbert

  • Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines.

    Frank Watjen;Raymond Baker;Mogens Engelstoff;Richard Herbert

  • Imidazole, triazole and tetrazole derivatives

    Raymond Baker;Victor G. Matassa;Leslie J. Street

  • Substituted morpholine derivatives and their use as therapeutic agents

    Raymond Baker;Timothy Harrison;Angus Murray Macleod;Andrew Pate Owens

  • Total synthesis of (+)-macbecin I

    Raymond Baker;Jose L. Castro

  • Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.

    Michael Rowley;Janusz J. Kulagowski;Alan P. Watt;Denise Rathbone

  • 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones : orally active antagonists of the glycine site on the NMDA receptor

    Kulagowski Jj;Baker R;Curtis Nr;Leeson Pd

  • 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors.

    Rowley M;Broughton Hb;Collins I;Baker R

  • Identification and synthesis of the major sex pheromone of the olive fly (Dacus oleae)

    Raymond Baker;Richard Herbert;Philip E. Howse;Owen T. Jones

  • 2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the NMDA receptor.

    Robert W. Carling;Paul D. Leeson;Angela M. Moseley;Raymond Baker

  • Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors

    Leslie J. Street;Raymond Baker;Jose L. Castro;Mark S. Chambers

  • Spiropiperidines as high-affinity, selective .sigma. ligands.

    Mark S. Chambers;Raymond Baker;David C. Billington;Anthony K. Knight

  • Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy

    Raymond Baker;Christopher J. Swain;Martin R. Teall;Brian J. Williams

  • 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex.

    Rowley M;Leeson Pd;Stevenson Gi;Moseley Am

  • Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them

    Raymond Baker;Timothy Harrison;Christopher John Swain;Brian John Williams

  • Pyrrolo-pyridine derivatives

    Raymond Baker;Neil Roy Curtis;Janusz Jozef Kulagowski;Paul David Leeson

  • .pi.-Allylmetal derivatives in organic synthesis

    Unknown

Frequent Co-Authors

Paul D. Leeson
Paul D. Leeson Loughborough University
Angus Murray Macleod
Angus Murray Macleod MSD (United States)
David A. Evans
David A. Evans Harvard University
Michael Rowley
Michael Rowley Pharmaron (United Kingdom)
Ian Collins
Ian Collins PharmEnable Therapeutics
Andrew B. Holmes
Andrew B. Holmes University of Melbourne
Richard Hargreaves
Richard Hargreaves Harvard Medical School
Richard G. Ball
Richard G. Ball MSD (United States)
Margaret A. Cascieri
Margaret A. Cascieri MSD (United States)
Timothy M. Willson
Timothy M. Willson University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Chemistry opens doors to various online degree options and career trajectories. For students exploring flexible options, understanding the costs and structure is crucial. For example, students interested in fields like criminal justice can learn more about how much does a criminal justice degree cost, which helps in budgeting their education. Additionally, choosing an accredited online criminal justice associate degree ensures the quality and recognition of the program, a consideration that applies across disciplines, including chemistry-related careers.

For those interested in legal aspects tied to chemistry, such as patent law or regulatory compliance, understanding various degrees for paralegals can provide useful insights into complementary career paths. Moreover, chemistry graduates often find roles in pharmaceutical companies, where knowledge of the product is essential. Aspiring professionals may explore roles highlighted in pharma sales rep salary details to understand career opportunities and earning potential in the pharmaceutical sales sector.

Best Scientists Citing Raymond Baker